MACKAY SHIELDS LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 14 filers reported holding CLOVIS ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MACKAY SHIELDS LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$99,0000.0%140,0000.0%0.00%
+50.0%
Q2 2022$99,000
-6.6%
140,0000.0%0.00%
+100.0%
Q1 2022$106,000
+7.1%
140,0000.0%0.00%0.0%
Q4 2021$99,000
-2.9%
140,0000.0%0.00%0.0%
Q3 2021$102,000
-1.9%
140,0000.0%0.00%0.0%
Q2 2021$104,000
-2.8%
140,0000.0%0.00%0.0%
Q1 2021$107,000
+8.1%
140,0000.0%0.00%0.0%
Q4 2020$99,000
-1.0%
140,0000.0%0.00%0.0%
Q3 2020$100,000
+14.9%
140,0000.0%0.00%0.0%
Q2 2020$87,000
+2.4%
140,0000.0%0.00%0.0%
Q1 2020$85,000
-5.6%
140,0000.0%0.00%0.0%
Q4 2019$90,000
-73.4%
140,000
-82.3%
0.00%
-50.0%
Q3 2019$338,000
-31.7%
790,0000.0%0.00%
-33.3%
Q2 2019$495,000
-2.8%
790,000
+21.5%
0.00%
-25.0%
Q1 2019$509,000
-27.6%
650,000
-35.0%
0.00%
-33.3%
Q4 2018$703,000
-9.4%
1,000,0000.0%0.01%0.0%
Q3 2018$776,000
-16.0%
1,000,0000.0%0.01%0.0%
Q2 2018$924,0001,000,0000.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Antara Capital LP 55,678,000$42,628,0003.59%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 30,066,000$22,875,0000.91%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 29,000,000$21,750,000,0000.31%
FARALLON CAPITAL MANAGEMENT LLC 51,910,000$39,243,0000.20%
OAKTREE CAPITAL MANAGEMENT LP 6,349,000$4,860,0000.07%
Psagot Value Holdings Ltd. 1,500,000$1,141,0000.03%
Allianz Asset Management GmbH 29,945,000$22,766,0000.02%
D. E. Shaw & Co., Inc. 25,050,000$19,155,0000.02%
AMERIPRISE FINANCIAL INC 42,200,000$31,887,0000.01%
PALISADE CAPITAL MANAGEMENT, LP 330,000$250,0000.01%
View complete list of CLOVIS ONCOLOGY INC shareholders